AndroGel Cost in Georgia 2026: Cash Pay, Insurance, Medicaid, and Compounded Alternatives

What Does AndroGel Actually Cost in Georgia in 2026?

The cash-pay price for brand AndroGel at Georgia retail pharmacies averages roughly $510 per month in 2026, matching AbbVie's published list price. That figure applies whether you fill at a Publix pharmacy in Atlanta or a regional independent in Savannah. Patients without insurance or with plans that exclude testosterone therapy absorb the full amount.

GoodRx and similar coupon platforms sometimes reduce that figure by 10 to 20 percent at participating pharmacies, putting the out-of-pocket cost between $408 and $460 for a 30-day supply of AndroGel 1.62%. These coupons are accepted at Walgreens, CVS, Kroger, and most Walmart pharmacies across the state. GoodRx discounts cannot be combined with federal insurance programs, so Medicaid and Medicare patients cannot use them legally. Prices shift with pharmacy contracts, so always call ahead to confirm the coupon price before you drive to the counter. [1]

The FDA-approved labeling for AndroGel specifies the 1% and 1.62% formulations for replacement therapy in adult males with primary or hypogonadotropic hypogonadism, a condition confirmed by low morning serum testosterone plus clinical symptoms. [2] Without a confirmed diagnosis meeting those criteria, commercial insurers and pharmacy benefit managers routinely deny coverage outright.

Georgia Medicaid Coverage for AndroGel: The Narrow Exception

Georgia Medicaid does not cover AndroGel or any testosterone gel product for the standard indication of male hypogonadism. The Georgia Department of Community Health Preferred Drug List places brand testosterone gels in a non-covered category for that indication. The one documented exception sits inside the type-2 diabetes therapeutic area, where testosterone deficiency can be considered a comorbid metabolic condition on a case-by-case prior-authorization basis. [3]

This policy affects tens of thousands of low-income Georgian men with symptomatic hypogonadism. The Endocrine Society's 2018 Clinical Practice Guideline on testosterone therapy states: "We recommend against prescribing testosterone therapy to men with testosterone deficiency who desire to maintain fertility or whose motivation for treatment is enhancement of athletic performance." Separately, the same guideline recommends confirming testosterone deficiency by a morning serum level below 264 ng/dL on two separate occasions before initiating therapy. [4] Georgia Medicaid's formulary gatekeeping adds a second layer of exclusion on top of those clinical thresholds.

Patients on Georgia Medicaid who carry a concurrent type-2 diabetes diagnosis may submit a prior-authorization request. Approvals are not guaranteed. Clinical documentation required typically includes two low morning testosterone values, an HbA1c confirming active diabetes management, and a prescriber attestation that testosterone therapy is medically necessary for glycemic reasons. This process can take two to four weeks. [3]

How Commercial Insurance Covers AndroGel in Georgia

Most commercial plans sold on the Georgia marketplace or offered through large employers place testosterone gels on Tier 3 or Tier 4 of their formulary. Tier 3 copays in 2026 commonly run $60 to $120 per 30-day supply after deductible, and Tier 4 specialty copays can hit $200 or more. The actual patient cost depends entirely on which plan, which PBM (CVS Caremark, Express Scripts, or OptumRx handle the bulk of Georgia commercial plans), and whether the deductible has been met for the year. [5]

Prior authorization is almost universal. Insurers typically require documentation of two morning serum testosterone values below the laboratory reference range, a clinical diagnosis of primary or secondary hypogonadism (ICD-10 code E29.1 or E23.0), and often a trial failure or contraindication to a generic testosterone option such as testosterone cypionate injection. [5]

Blue Cross Blue Shield of Georgia, Ambetter from Peach State Health Plan, and UnitedHealthcare Community Plan each maintain slightly different PA criteria. Calling the pharmacy benefits line before the prescription is sent gives patients a clearer picture of expected costs. Step therapy requirements, where an insurer mandates a cheaper drug first, are common and may require a prescriber exception letter if the patient has a medical reason to avoid injections.

The TRAVERSE trial (N=5,246), published in the New England Journal of Medicine in 2023, found that testosterone replacement therapy did not increase major adverse cardiovascular events compared to placebo in men with hypogonadism and pre-existing or high-risk cardiovascular disease. [6] That finding has shifted some payer medical policies toward approving testosterone therapy for men with controlled cardiovascular risk factors, which may matter for prior-authorization appeals in Georgia.

The AbbVie Savings Card: How It Works for Georgia Patients

AbbVie's MyAbbVie Assist program offers two pathways. Commercially insured patients who meet income or copay thresholds may qualify for a copay card that reduces monthly out-of-pocket costs to as low as $0, with AbbVie covering up to a set annual cap (terms updated annually; confirm at abbvie.com). Uninsured or underinsured patients below 400 percent of the federal poverty level may qualify for free or deeply discounted product through the patient assistance program. [7]

Georgia patients apply online or through their prescribing provider. Approval is typically instant for the copay card if the patient has qualifying commercial insurance. The card does not work with Medicaid, Medicare Part D, or any government-funded insurance program, per federal anti-kickback rules. Pharmacies participating in the savings program include most major retail chains in Georgia. [7]

One practical note: the savings card covers the brand product specifically. If a pharmacy substitutes a generic testosterone gel (generic 1.62% formulations entered the market in recent years), the AbbVie card will not apply to the generic version. Ask the pharmacist to fill the brand product if you are using the AbbVie card.

Compounded Testosterone Gel in Georgia: Legality and Cost

Compounded testosterone gel is legal in Georgia when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription. The Drug Quality and Security Act of 2013 created the 503A designation for traditional compounding pharmacies that fill individual prescriptions, distinguishing them from 503B outsourcing facilities that produce sterile compounded drugs in bulk. [8]

Georgia-based 503A pharmacies may legally compound testosterone gel in concentrations not commercially available (for example, 2%, 5%, or 10% concentrations for specific dosing needs) when a licensed prescriber writes the order for a specific patient. The FDA has occasionally issued guidance limiting compounding of drugs that are essentially copies of commercially available products, but testosterone gel compounding remains permissible where a clinical rationale distinguishes the compounded product from the brand. [8]

The cost difference is substantial. Compounded testosterone gel from a licensed Georgia 503A pharmacy typically runs $120 per month for a 30-day supply, compared to the $510 brand price. Some compounding pharmacies bundle testosterone gel with a telehealth consultation and follow-up testing, bringing the total monthly program cost to $150 to $200 for comprehensive care. Patients should verify that any compounding pharmacy they use holds a current Georgia State Board of Pharmacy license and PCAB accreditation where available. [9]

The HealthRX clinical team uses the following three-tier cost framework when counseling Georgia patients on testosterone gel options:

Tier 1 (lowest cost, ~$120/month): Compounded testosterone gel via licensed Georgia 503A pharmacy, appropriate for patients without commercial coverage or with high copays, using telehealth prescribing.

Tier 2 (mid cost, $0 to $120/month with card): Brand AndroGel with AbbVie copay card for commercially insured patients on qualifying plans.

Tier 3 (highest cost, $408 to $510/month cash): Brand AndroGel at retail cash price or with GoodRx coupon, for patients without insurance or savings card access.

Clinical Evidence Supporting Testosterone Gel Therapy

The Testosterone Trials (T-Trials), a coordinated set of seven placebo-controlled trials in 790 hypogonadal men aged 65 or older, found that one year of testosterone therapy (titrated to maintain serum testosterone between 500 and 1 to 000 ng/dL) significantly improved sexual desire, erectile function, and bone density compared to placebo. [10] These findings, published in JAMA and the New England Journal of Medicine between 2016 and 2017, support the use of testosterone gel as first-line topical therapy in men with confirmed hypogonadism.

The T-Trials used a topical gel formulation to achieve target serum testosterone levels. The sexual function trial (N=470) reported that the International Index of Erectile Function score improved by 2.64 points with testosterone versus 0.85 points with placebo (P<0.001). [10] The bone density trial showed a 3.0 percent increase in trabecular bone volume fraction in the spine with testosterone versus 0.8 percent with placebo. [11]

The Endocrine Society guideline recommends topical gel as an acceptable delivery method, noting that gels produce more stable daily testosterone levels compared to short-acting injections, which create peaks and troughs. [4] Stable levels may matter for symptom management, particularly for men whose primary complaints are fatigue and cognitive fog rather than libido alone.

The FDA label for AndroGel carries a black-box warning about secondary exposure risk: children and women who come into skin contact with testosterone gel application sites have developed signs of virilization. [2] Patients should cover the application site after the gel dries and wash hands thoroughly. This warning is pharmacologically identical across brand and compounded formulations.

Telehealth Prescribing of AndroGel in Georgia

Georgia law permits telehealth prescribing of Schedule III controlled substances, which includes testosterone, when the prescribing clinician completes a valid patient evaluation that includes a documented patient history and review of laboratory results. A prescriber may not write a testosterone prescription in Georgia based solely on a symptom questionnaire; a confirmed low testosterone value from a Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory is required to meet standard of care. [12]

Several national TRT telehealth platforms operate legally in Georgia, including services that collect blood work through local labs like LabCorp or Quest Diagnostics before issuing a prescription. This model allows patients to skip an in-person visit while maintaining a medically appropriate evaluation. [12]

Georgia does not require an in-person physical exam as a prerequisite for a testosterone prescription as of 2025 to 2026 regulatory guidelines, though individual prescribers may impose their own standards. Patients should confirm the specific lab and clinical requirements with any telehealth service before paying for a membership or consultation fee.

AndroGel Dosing and Administration in Georgia Practice

The FDA-approved starting dose for AndroGel 1.62% is 40.5 mg (two pump actuations) applied once daily to the upper arm or shoulder. Dose adjustments are made based on morning serum testosterone measured 14 days after initiation, with a target range of 300 to 1 to 000 ng/dL per FDA labeling. [2] The maximum approved dose is 81 mg daily.

For AndroGel 1%, the starting dose is 50 mg (one packet or five pump actuations) applied once daily to the shoulders, upper arms, or abdomen. The dose range runs from 25 mg to 100 mg daily based on serum response. [2]

Georgia prescribers managing patients on compounded testosterone gel often use concentrations of 5% or 10% applied in smaller volumes (0.5 mL or 1 mL), which reduces the skin surface area exposed and may improve adherence. Dosing equivalence between brand and compounded products depends on the base formulation's absorption characteristics; patients switching from brand to compounded gel should recheck serum testosterone 14 days after the switch. [9]

Monitoring Costs in Georgia: What to Budget Beyond the Prescription

Testosterone therapy requires ongoing laboratory monitoring. Standard practice per the Endocrine Society guideline includes serum testosterone, hematocrit, and PSA checks at 3 months after initiation, then annually. [4] A basic testosterone panel at a Georgia LabCorp or Quest site without insurance runs $40 to $80 per draw. Hematocrit and PSA together add roughly $30 to $60 per lab visit.

Elevated hematocrit (above 54 percent) is the most common laboratory-detected adverse effect of testosterone therapy and requires dose reduction or temporary discontinuation. [4] Georgia patients on compounded gel programs through telehealth platforms typically have these labs included in their monthly program fee, which changes the true cost comparison between telehealth-compounded and retail-brand options.

PSA monitoring matters because testosterone can stimulate prostate tissue. The Endocrine Society recommends against initiating testosterone therapy in men with a PSA above 4 ng/mL without a urology evaluation, or above 3 ng/mL in men at high risk for prostate cancer. [4] Georgia men with a family history of prostate cancer or African ancestry, who carry a statistically elevated baseline risk per National Cancer Institute data, should discuss prostate surveillance with their prescriber before starting any testosterone formulation. [13]

Switching From Brand AndroGel to a Cheaper Alternative in Georgia

Patients currently paying full retail price for brand AndroGel in Georgia have three realistic cost-reduction paths. First, apply for the AbbVie copay card if commercially insured. Second, ask the prescriber to write a prescription for a generic testosterone gel (available at several Georgia pharmacies for $80 to $160 per month depending on the formulation and pharmacy). Third, transition to a compounded testosterone gel through a licensed 503A pharmacy, either through an existing prescriber or via a telehealth platform. [9]

The transition to compounded gel requires a new prescription written for a specific compounded formulation. The prescriber should confirm that the compounding pharmacy is licensed in Georgia and that the specific base formulation has documented bioavailability data. Not all compounding bases absorb equally; hydroalcoholic gels (similar to brand AndroGel's base) tend to show better absorption than cream bases for most patients. [9]

Testosterone cypionate injection (generic, 200 mg/mL) remains the lowest-cost FDA-approved testosterone option in Georgia, available for as little as $30 to $50 per month at retail pharmacies with GoodRx. Patients who can tolerate weekly or biweekly self-injection may achieve comparable serum levels at a fraction of the gel cost. The trade-off is injection-related peaks and troughs that some patients find intolerable. [14]

Key Differences Between AndroGel 1% and AndroGel 1.62%

AndroGel 1.62% delivers the same testosterone dose as AndroGel 1% in a smaller application volume, which reduces skin surface area exposure and transfer risk. The 1.62% formulation was approved by the FDA in 2011 specifically to address secondary exposure concerns identified in post-marketing reports with the 1% product. [2]

From a pricing standpoint, both concentrations carry similar retail prices in Georgia. The 1.62% version uses a metered-dose pump, while the 1% version is available in both packets and a pump. Pharmacies in Georgia stock both, though the 1.62% pump tends to be more reliably available at larger chain locations. Some smaller independent pharmacies in rural Georgia may need two to three days to order the 1.62% pump if it is not in stock. Call ahead.